• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在患有2型糖尿病的肥胖受试者中,循环血管紧张素II与体脂堆积及胰岛素抵抗相关。

Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus.

作者信息

Saiki Atsuhito, Ohira Masahiro, Endo Kei, Koide Nobukiyo, Oyama Tomokazu, Murano Takeyoshi, Watanabe Hitoshi, Miyashita Yoh, Shirai Kohji

机构信息

Center of Diabetes, Endocrine and Metabolism, Toho University Sakura Medical Center, Sakura-City, Chiba 285-8741, Japan.

出版信息

Metabolism. 2009 May;58(5):708-13. doi: 10.1016/j.metabol.2009.01.013.

DOI:10.1016/j.metabol.2009.01.013
PMID:19375596
Abstract

Adipocytes express all components of the renin-angiotensin system, and the renin-angiotensin system is involved in obesity and insulin resistance. Circulating angiotensin II (Ang II) is detectable in blood, but its significance in human obesity remains unknown. The aim of this study was to investigate plasma Ang II in obese patients with type 2 diabetes mellitus (T2D) and the change during weight loss. Fifty Japanese obese subjects with T2D (body weight, 75.0 +/- 14.1 kg; body mass index, 29.1 +/- 3.7 kg/m(2); visceral fat area [VFA], 169.3 +/- 54.3 cm(2); hemoglobin A(1c), 7.6% +/- 1.5%) were enrolled. The subjects were prescribed a diet of daily caloric intake of 20 kcal/kg for 24 weeks. Plasma Ang II was measured by radioimmunoassay. Leptin, adiponectin, and lipoprotein lipase mass in preheparin serum were also measured as adipocyte-derived factors. After 24 weeks of weight reduction diet, the mean body weight, VFA, and hemoglobin A(1c) decreased significantly by 2.3%, 7.0%, and 8.3%, respectively. The mean plasma Ang II decreased by 24% (P < .0001) and correlated with body weight both at baseline (r = 0.425, P = .0018) and at 24 weeks (r = 0.332, P = .0181). The change in Ang II correlated with changes in body weight (r = 0.335, P = .0167) and VFA (r = 0.329, P = .0191). The change in Ang II also correlated positively with change in leptin (r = 0.348, P = .0127) and tended to correlate negatively with change in lipoprotein lipase mass in preheparin serum (r = -0.260, P = .0683), which is a marker of insulin sensitivity. Plasma Ang II is associated with body weight, decreases during weight loss, and is associated with markers of insulin resistance in obese subjects with T2D.

摘要

脂肪细胞表达肾素-血管紧张素系统的所有成分,且肾素-血管紧张素系统与肥胖和胰岛素抵抗有关。循环中的血管紧张素II(Ang II)在血液中可检测到,但其在人类肥胖中的意义尚不清楚。本研究的目的是调查2型糖尿病(T2D)肥胖患者的血浆Ang II水平以及体重减轻期间的变化。招募了50名日本T2D肥胖受试者(体重75.0±14.1kg;体重指数29.1±3.7kg/m²;内脏脂肪面积[VFA]169.3±54.3cm²;糖化血红蛋白7.6%±1.5%)。受试者被规定每日热量摄入为20kcal/kg的饮食,持续24周。采用放射免疫分析法测定血浆Ang II。还测定了肝素化前血清中的瘦素、脂联素和脂蛋白脂肪酶质量作为脂肪细胞衍生因子。经过24周的减重饮食后,平均体重、VFA和糖化血红蛋白分别显著下降了2.3%、7.0%和8.3%。平均血浆Ang II下降了24%(P<.0001),且在基线时(r=0.425,P=.0018)和24周时(r=0.332,P=.0181)均与体重相关。Ang II的变化与体重变化(r=0.335,P=.0167)和VFA变化(r=0.329,P=.0191)相关。Ang II的变化也与瘦素变化呈正相关(r=0.348,P=.0127),并倾向于与肝素化前血清中脂蛋白脂肪酶质量变化呈负相关(r=-0.260,P=.0683),脂蛋白脂肪酶质量是胰岛素敏感性的标志物。血浆Ang II与体重相关,在体重减轻期间降低,并且与T2D肥胖受试者的胰岛素抵抗标志物相关。

相似文献

1
Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus.在患有2型糖尿病的肥胖受试者中,循环血管紧张素II与体脂堆积及胰岛素抵抗相关。
Metabolism. 2009 May;58(5):708-13. doi: 10.1016/j.metabol.2009.01.013.
2
Pioglitazone decreases plasma angiotensin II concentration in type 2 diabetes.吡格列酮可降低 2 型糖尿病患者的血浆血管紧张素 II 浓度。
J Atheroscler Thromb. 2010 Jun 30;17(6):651-7. doi: 10.5551/jat.4002. Epub 2010 May 13.
3
Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women.脂肪分布、肌肉脂质含量、脂肪细胞因子与胰岛素抵抗之间的相互关系:老年女性适度体重减轻的影响。
Am J Clin Nutr. 2006 Nov;84(5):1193-9. doi: 10.1093/ajcn/84.5.1193.
4
The ratio of leptin to adiponectin can be used as an index of insulin resistance.瘦素与脂联素的比值可作为胰岛素抵抗的一个指标。
Metabolism. 2008 Feb;57(2):268-73. doi: 10.1016/j.metabol.2007.09.011.
5
Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.肥胖、2型糖尿病及单一药物治疗中的脂联素与C反应蛋白
Metabolism. 2004 Nov;53(11):1454-61. doi: 10.1016/j.metabol.2004.06.013.
6
Relationship of adipokine to insulin sensitivity and glycemic regulation in obese women--the effect of body weight reduction by caloric restriction.肥胖女性中脂肪因子与胰岛素敏感性及血糖调节的关系——热量限制减重的影响
Vojnosanit Pregl. 2013 Mar;70(3):284-91. doi: 10.2298/vsp1303284v.
7
Laparoscopic Sleeve Gastrectomy Significantly Increases Serum Lipoprotein Lipase Level in Obese Patients.腹腔镜袖状胃切除术显著增加肥胖患者的血清脂蛋白脂肪酶水平。
Obes Facts. 2019;12(3):357-368. doi: 10.1159/000500360. Epub 2019 Jun 5.
8
Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus.在患有2型糖尿病的日本男性中,脂联素水平过低与内脏脂肪堆积及胰岛素抵抗相关。
Metabolism. 2003 Oct;52(10):1274-8. doi: 10.1016/s0026-0495(03)00195-1.
9
Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.2型糖尿病患者脂联素-瘦素比值与胰岛素抵抗参数之间的相关性
Metabolism. 2005 Mar;54(3):281-6. doi: 10.1016/j.metabol.2004.09.006.
10
Insulin-leptin-visceral fat relation during weight loss.减肥期间胰岛素-瘦素-内脏脂肪的关系
Pancreas. 2001 Aug;23(2):197-203. doi: 10.1097/00006676-200108000-00010.

引用本文的文献

1
Skeletal Muscle and Cardiovascular Health.骨骼肌与心血管健康。
Adv Exp Med Biol. 2025;1478:631-659. doi: 10.1007/978-3-031-88361-3_26.
2
New Markers for the Assessment of Microvascular Complications in Patients with Metabolic Syndrome.用于评估代谢综合征患者微血管并发症的新标志物
Metabolites. 2025 Mar 10;15(3):184. doi: 10.3390/metabo15030184.
3
Association of estimated glucose disposal rate with metabolic syndrome prevalence and mortality risks: a population-based study.估计的葡萄糖处置率与代谢综合征患病率及死亡风险的关联:一项基于人群的研究。
Cardiovasc Diabetol. 2025 Jan 22;24(1):38. doi: 10.1186/s12933-025-02599-7.
4
Therapeutic opportunities in targeting the protective arm of the renin-angiotensin system to improve insulin sensitivity: a mechanistic review.靶向肾素-血管紧张素系统的保护分支以改善胰岛素敏感性的治疗机会:一项机制综述
Hypertens Res. 2024 Dec;47(12):3397-3408. doi: 10.1038/s41440-024-01909-y. Epub 2024 Oct 3.
5
Research advances in the therapy of metabolic syndrome.代谢综合征治疗的研究进展
Front Pharmacol. 2024 Jul 30;15:1364881. doi: 10.3389/fphar.2024.1364881. eCollection 2024.
6
Renin-Angiotensin System: Updated Understanding and Role in Physiological and Pathophysiological States.肾素-血管紧张素系统:最新认识及其在生理和病理生理状态中的作用
Cureus. 2023 Jun 21;15(6):e40725. doi: 10.7759/cureus.40725. eCollection 2023 Jun.
7
Suppressed vascular Rho-kinase activation is a protective cardiovascular mechanism in obese female mice.肥胖雌性小鼠中受抑制的血管 Rho 激酶激活是一种保护性心血管机制。
Biosci Rep. 2023 Jul 26;43(7). doi: 10.1042/BSR20230672.
8
Mediterranean diet lowers all-cause and cardiovascular mortality for patients with metabolic syndrome.地中海饮食可降低代谢综合征患者的全因死亡率和心血管死亡率。
Diabetol Metab Syndr. 2023 May 23;15(1):107. doi: 10.1186/s13098-023-01052-7.
9
Visceral fat and attribute-based medicine in chronic kidney disease.内脏脂肪与基于属性的慢性肾脏病医学
Front Endocrinol (Lausanne). 2023 Feb 9;14:1097596. doi: 10.3389/fendo.2023.1097596. eCollection 2023.
10
Pediatric endocrinopathies related to COVID-19: an update.与 COVID-19 相关的儿科内分泌疾病:最新进展。
World J Pediatr. 2023 Sep;19(9):823-834. doi: 10.1007/s12519-022-00662-x. Epub 2022 Dec 8.